Also, regarding the importance of SLC3A2-NRG1 fusion in lung cancer, in another study, it was shown that KRAS enhances tumor growth in SLC3A2-NRG1–positive lung cancer cells through ADAM17-mediated NRG1 cleavage. Here, SLC3A2 is linked to lung carcinoma.